{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:15:13Z","timestamp":1784031313230,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejca.2024.114234","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T14:04:21Z","timestamp":1722002661000},"page":"114234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Comparison of Khorana vs. ONKOTEV predictive score to individualize anticoagulant prophylaxis in outpatients with cancer"],"prefix":"10.1016","volume":"209","author":[{"given":"Chiara Alessandra","family":"Cella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Djulbegovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iztok","family":"Hozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Lordick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Bagnardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Frassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Gervaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2024.114234_bib1","doi-asserted-by":"crossref","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. Oct 8 2016;388(10053):1459\u20131544. doi:10.1016\/s0140\u20136736(16)31012\u20131.","DOI":"10.1016\/S0140-6736(16)31012-1"},{"issue":"2","key":"10.1016\/j.ejca.2024.114234_bib2","first-page":"173","article-title":"Venous and Arterial Thromboembolism in Patients With Cancer","volume":"3","author":"Gervaso","year":"2021","journal-title":"JACC: CardioOncology State---Art Rev JACC CardioOncol"},{"issue":"5","key":"10.1016\/j.ejca.2024.114234_bib3","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.21037\/apm-20-47","article-title":"Primary prophylaxis for venous thromboembolism in ambulatory cancer patients: a systematic review and network meta-analysis","volume":"9","author":"Xin","year":"2020","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.ejca.2024.114234_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.thromres.2018.08.023","article-title":"Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis","volume":"170","author":"Vedovati","year":"2018","journal-title":"Thromb Res"},{"issue":"12","key":"10.1016\/j.ejca.2024.114234_bib5","article-title":"Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy","volume":"12","author":"Rutjes","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2024.114234_bib6","series-title":"Clinical practice guidelines we can trust","author":"Graham","year":"2011"},{"issue":"10092","key":"10.1016\/j.ejca.2024.114234_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(16)31592-6","article-title":"Progress in evidence-based medicine: a quarter century on","volume":"390","author":"Djulbegovic","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejca.2024.114234_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/M18-3667","article-title":"The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement","volume":"172","author":"Kent","year":"2020","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ejca.2024.114234_bib9","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1055\/a-1642-4572","article-title":"Prognostic Factors for Venous Thromboembolism in Patients with Solid Tumours on Systemic Therapy: A Systematic Review","volume":"5","author":"Lee","year":"2021","journal-title":"TH Open"},{"issue":"4","key":"10.1016\/j.ejca.2024.114234_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.ejca.2024.114234_bib11","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1016\/S1470-2045(19)30336-5","article-title":"2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"20","author":"Farge","year":"2019","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2024.114234_bib12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update","volume":"38","author":"Key","year":"2020","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2024.114234_bib13","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3324\/haematol.2017.169060","article-title":"Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study","volume":"102","author":"van Es","year":"2017","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.ejca.2024.114234_bib14","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejca.2024.114234_bib15","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1200\/JOP.2015.004473","article-title":"American Society of Clinical Oncology. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"11","author":"Lyman","year":"2015","journal-title":"J Oncol Pract"},{"issue":"5","key":"10.1016\/j.ejca.2024.114234_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1634\/theoncologist.2016-0246","article-title":"Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study","volume":"22","author":"Cella","year":"2017","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.ejca.2024.114234_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0010","article-title":"Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer","volume":"6","author":"Cella","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejca.2024.114234_bib18","series-title":"Medical Decision Making","author":"Sox","year":"2013"},{"issue":"8","key":"10.1016\/j.ejca.2024.114234_bib19","first-page":"1271","article-title":"Generalized Decision Curve Analysis for Explicit Comparison of Treatment Effects","volume":"29","author":"Hozo","year":"2023","journal-title":"J Eval Clin Pract 2023"},{"issue":"20","key":"10.1016\/j.ejca.2024.114234_bib20","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1182\/bloodadvances.2020003115","article-title":"Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis","volume":"4","author":"Bosch","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.ejca.2024.114234_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jep.13194","article-title":"Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? a systematic review, network meta-analysis, and decision analysis.","volume":"26","author":"Djulbegovic","year":"2020","journal-title":"J Eval Clin Pr"},{"issue":"6","key":"10.1016\/j.ejca.2024.114234_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision Curve Analysis: A Novel Method for Evaluating Prediction Models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.ejca.2024.114234_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/jep.13915","article-title":"\"Generalized decision curve analysis for explicit comparison of treatment effects","author":"Hozo","year":"2023","journal-title":"J Eval Clin"},{"issue":"2","key":"10.1016\/j.ejca.2024.114234_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jep.13091","article-title":"The threshold model revisited","volume":"25","author":"Djulbegovic","year":"2019","journal-title":"J Eval Clin Pract"},{"issue":"11","key":"10.1016\/j.ejca.2024.114234_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020395","article-title":"The clinical interpretation of research","volume":"2","author":"Pauker","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejca.2024.114234_bib26","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJM198005153022003","article-title":"The threshold approach to clinical decision making","volume":"302","author":"Pauker","year":"1980","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejca.2024.114234_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12421","article-title":"When is rational to order a diagnostic test, or prescribe treatment: the threshold model as an explanation of practice variation","volume":"45","author":"Djulbegovic","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejca.2024.114234_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0167-6296(98)00039-3","article-title":"The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies","volume":"18","author":"Claxon","year":"1999","journal-title":"J Health Econ"},{"key":"10.1016\/j.ejca.2024.114234_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.thromres.2018.02.144","article-title":"Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis","volume":"173","author":"Li","year":"2019","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.ejca.2024.114234_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12959-022-00399-7","article-title":"Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis","volume":"20","author":"Rungjirajittranon","year":"2022","journal-title":"Thromb J"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924008906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924008906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T16:46:31Z","timestamp":1729615591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804924008906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":30,"alternative-id":["S0959804924008906"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2024.114234","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Khorana vs. ONKOTEV predictive score to individualize anticoagulant prophylaxis in outpatients with cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2024.114234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114234"}}